80 FR 38450 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 128 (July 6, 2015)

Page Range		38450-38451
FR Document		2015-16526

Federal Register, Volume 80 Issue 128 (Monday, July 6, 2015)

[Federal Register Volume 80, Number 128 (Monday, July 6, 2015)]
[Notices]
[Pages 38450-38451]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-16526]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; R13 Conference Grant Review (PA 13-347).
    Date: July 23, 2015.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Susan O. McGuire, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., 
Room 4245, Rockville, MD 20852, 301-435-1426, 
[email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel;

[[Page 38451]]

Mechanism for Time-Sensitive Drug Abuse Research (R21).
    Date: July 24, 2015.
    Time: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Gerald L. McLaughlin, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4238, MSC 9550, 
Bethesda, MD 20892-9550, 301-402-6626, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: June 30, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-16526 Filed 7-2-15; 8:45 am]
 BILLING CODE 4140-01-P

38450 Federal Register / Vol. 80, No. 128 / Monday, July 6, 2015 / Notices

those in section 582, such as verification Research, Care, and Services provides dementia, and others. Following this
related to suspect and illegitimate advice on how to prevent or reduce the session, the Advisory Council will also
product (including quarantine, burden of Alzheimer’s disease and hold a discussion of the expected
investigation, notification and related dementias on people with the bypass budget from NIA, required in the
recordkeeping) and requirements related disease and their caregivers. During the CRomnibus Bill. The Council will also
to engaging in transactions only with July meeting, the Advisory Council will discuss updates to international events
authorized trading partners. The hear from experts on related dementias, on dementia.
guidance document explains the scope such as Frontotemporal dementia, Lewy Procedure and Agenda: This meeting
of the compliance policy in further Body dementia, and others. Following is open to the public. Please allow 30
detail. this session, the Advisory Council will minutes to go through security and walk
The guidance represents the current also hold a discussion of the expected to the meeting room. The meeting will
thinking of FDA on this topic. It does bypass budget from NIA, required in the also be webcast at www.hhs.gov/live .
not establish any rights for any person CRomnibus Bill. The Council will also Authority: 42 U.S.C. 11225; Section 2(e)(3)
and is not binding on FDA or the public. discuss updates to international events of the National Alzheimer’s Project Act. The
You can use an alternative approach if on dementia. panel is governed by provisions of Public
it satisfies the requirements of the DATES: The meeting will be held on Law 92–463, as amended (5 U.S.C. Appendix
applicable statutes and regulations. April 28th, 2015 from 9:00 a.m. to 5:00 2), which sets forth standards for the
p.m. EDT. formation and use of advisory committees.
II. Comments
ADDRESSES: The meeting will be held in Dated: June 26, 2015.
Interested persons may submit either the Great Hall in the Hubert H. Richard G. Frank,
electronic comments to http:// Humphrey Building, 200 Independence Assistant Secretary for Planning and
www.regulations.gov or written Avenue SW., Washington, DC 20201. Evaluation.
comments to the Division of Dockets Comments: Time is allocated in the [FR Doc. 2015–16490 Filed 7–2–15; 8:45 am]
Management (HFA–305), Food and Drug afternoon on the agenda to hear public BILLING CODE 4150–05–P
Administration, 5630 Fishers Lane, Rm. comments. The time for oral comments
1061, Rockville, MD 20852. Identify all will be limited to two (2) minutes per
comments with the docket number individual. In lieu of oral comments, DEPARTMENT OF HEALTH AND
found in brackets in the heading of this formal written comments may be HUMAN SERVICES
document. Received comments may be submitted for the record to Rohini
seen in the Division of Dockets Khillan, OASPE, 200 Independence National Institutes of Health
Management between 9 a.m. and 4 p.m., Avenue SW., Room 424E, Washington,
Monday through Friday, and will be National Institute on Drug Abuse;
DC 20201. Comments may also be sent
posted to the docket at http:// Notice of Closed Meetings
to napa@hhs.gov. Those submitting
www.regulations.gov. written comments should identify Pursuant to section 10(d) of the
III. Electronic Access themselves and any relevant Federal Advisory Committee Act, as
organizational affiliations. amended (5 U.S.C. App), notice is
Persons with access to the Internet
FOR FURTHER INFORMATION CONTACT: hereby given of the following meetings.
may obtain the document at http:// The meetings will be closed to the
www.fda.gov/Drugs/ Rohini Khillan (202) 690–5932,
rohini.khillan@hhs.gov. Note: Seating public in accordance with the
GuidanceCompliance provisions set forth in sections
RegulatoryInformation/Guidances/ may be limited. Those wishing to attend
the meeting must send an email to 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
default.htm, http://www.fda.gov/ as amended. The grant applications and
BiologicsBloodVaccines/ napa@hhs.gov and put ‘‘July 27 Meeting
Attendance’’ in the Subject line by the discussions could disclose
GuidanceCompliance confidential trade secrets or commercial
RegulatoryInformation/Guidances/ Friday, July 17, so that their names may
be put on a list of expected attendees property such as patentable material,
default.htm, or http:// and personal information concerning
www.regulations.gov. and forwarded to the security officers at
the Department of Health and Human individuals associated with the grant
Dated: June 29, 2015. Services. Any interested member of the applications, the disclosure of which
Leslie Kux, public who is a non-U.S. citizen should would constitute a clearly unwarranted
Associate Commissioner for Policy. include this information at the time of invasion of personal privacy.
[FR Doc. 2015–16401 Filed 7–2–15; 8:45 am] registration to ensure that the Name of Committee: National Institute on
BILLING CODE 4164–01–P appropriate security procedure to gain Drug Abuse Special Emphasis Panel; R13
entry to the building is carried out. Conference Grant Review (PA 13–347).
Although the meeting is open to the Date: July 23, 2015.
DEPARTMENT OF HEALTH AND Time: 1:00 p.m. to 3:00 p.m.
public, procedures governing security
Agenda: To review and evaluate grant
HUMAN SERVICES and the entrance to Federal buildings applications.
may change without notice. If you wish Place: National Institutes of Health,
Advisory Council on Alzheimer’s to make a public comment, you must Neuroscience Center, 6001 Executive
Research, Care, and Services; Meeting note that within your email. Boulevard, Rockville, MD 20852 (Virtual
SUPPLEMENTARY INFORMATION: Notice of Meeting).
AGENCY: Assistant Secretary for
these meetings is given under the Contact Person: Susan O. McGuire, Ph.D.,
Planning and Evaluation, HHS. Scientific Review Officer, Office of
Lhorne on DSK7TPTVN1PROD with NOTICES

ACTION: Notice of meeting. Federal Advisory Committee Act (5 Extramural Affairs, National Institute on
U.S.C. App. 2, section 10(a)(1) and Drug Abuse, National Institutes of Health,
SUMMARY: This notice announces the (a)(2)). DHHS, 6001 Executive Blvd., Room 4245,
public meeting of the Advisory Council Topics of the Meeting: The Advisory Rockville, MD 20852, 301–435–1426,
on Alzheimer’s Research, Care, and Council will hear from experts on mcguireso@mail.nih.gov.
Services (Advisory Council). The related dementias, such as Name of Committee: National Institute on
Advisory Council on Alzheimer’s Frontotemporal dementia, Lewy Body Drug Abuse Special Emphasis Panel;

VerDate Sep<11>2014 14:37 Jul 02, 2015 Jkt 235001 PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 E:\FR\FM\06JYN1.SGM 06JYN1

Federal Register / Vol. 80, No. 128 / Monday, July 6, 2015 / Notices 38451

Mechanism for Time-Sensitive Drug Abuse DEPARTMENT OF HEALTH AND Contact Person: Jose H. Guerrier, Ph.D.,
Research (R21). HUMAN SERVICES Scientific Review Officer, Center for
Date: July 24, 2015. Scientific Review, National Institutes of
Time: 1:00 p.m. to 2:00 p.m. National Institutes of Health Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–435–
Agenda: To review and evaluate grant
Center for Scientific Review Notice of 1137, guerriej@csr.nih.gov.
applications.
Closed Meetings Name of Committee: Center for Scientific
Place: National Institutes of Health,
Review Special Emphasis Panel; Member
Neuroscience Center, 6001 Executive Conflict: AIDS and AIDS Related Research.
Pursuant to section 10(d) of the
Boulevard, Rockville, MD 20852 (Telephone Date: July 29, 2015.
Federal Advisory Committee Act, as
Conference Call). Time: 2:30 p.m. to 4:30 p.m.
amended (5 U.S.C. App.), notice is
Contact Person: Gerald L. McLaughlin, Agenda: To review and evaluate grant
Ph.D., Scientific Review Officer, Office of
hereby given of the following meetings. applications.
The meetings will be closed to the Place: National Institutes of Health, 6701
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
public in accordance with the Rockledge Drive, Bethesda, MD 20892,
Blvd., Room 4238, MSC 9550, Bethesda, MD
provisions set forth in sections (Telephone Conference Call).
20892–9550, 301–402–6626, gm145a@
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Contact Person: Jose H. Guerrier, Ph.D.,
as amended. The grant applications and Scientific Review Officer, Center for
nih.gov. Scientific Review, National Institutes of
the discussions could disclose
(Catalogue of Federal Domestic Assistance Health, 6701 Rockledge Drive, Room 5218,
confidential trade secrets or commercial
Program Nos.: 93.279, Drug Abuse and MSC 7852, Bethesda, MD 20892, 301–435–
property such as patentable material, 1137, guerriej@csr.nih.gov.
Addiction Research Programs, National
and personal information concerning
Institutes of Health, HHS) Name of Committee: Center for Scientific
individuals associated with the grant Review Special Emphasis Panel; Member
Dated: June 30, 2015. applications, the disclosure of which Conflict: Diabetes and Obesity.
Michelle Trout, would constitute a clearly unwarranted Date: July 30, 2015.
Program Analyst, Office of Federal Advisory invasion of personal privacy. Time: 1:00 p.m. to 5:30 p.m.
Committee Policy. Agenda: To review and evaluate grant
Name of Committee: Center for Scientific
applications.
[FR Doc. 2015–16526 Filed 7–2–15; 8:45 am] Review Special Emphasis Panel; PAR Panel:
Place: National Institutes of Health, 6701
Adolescent Brain Cognitive Development
BILLING CODE 4140–01–P Rockledge Drive, Bethesda, MD 20892,
(ABCD) Study—Coordinating Center and (Telephone Conference Call).
Data Analysis and Informatics Center (U24). Contact Person: John Bleasdale, Ph.D.,
Date: July 16, 2015. Scientific Review Officer, Center for
DEPARTMENT OF HEALTH AND Time: 10:00 a.m. to 5:00 p.m.
HUMAN SERVICES Scientific Review, National Institutes of
Agenda: To review and evaluate grant Health, 6701 Rockledge Drive, Room 6170,
applications. MSC 7892, Bethesda, MD 20892, 301–435–
National Institutes of Health Place: National Institutes of Health, 6701 4514, bleasdaleje@csr.nih.gov.
Rockledge Drive, Bethesda, MD 20892.
Name of Committee: Center for Scientific
Office of the Director Notice of Charter Contact Person: Heidi B Friedman, Ph.D.,
Review Special Emphasis Panel; PAR–13–
Renewal Scientific Review Officer, Center for
385: Epigenetics in Gametogenesis and
Scientific Review, National Institutes of Transgenerational Inheritance.
In accordance with Title 41 of the Health, 6701 Rockledge Drive, Room 1012A, Date: July 31, 2015.
U.S. Code of Federal Regulations, MSC 7770, Bethesda, MD 20892, 301–379– Time: 3:00 p.m. to 4:00 p.m.
5632, hfriedman@csr.nih.gov. Agenda: To review and evaluate grant
Section 102–3.65(a), notice is hereby This notice is being published less than 15
given that the Charter for the Sickle Cell applications.
days prior to the meeting due to the timing Place: National Institutes of Health, 6701
Disease Advisory Council (SCDAC) was limitations imposed by the review and Rockledge Drive, Bethesda, MD 20892,
renewed for an additional two-year funding cycle. (Telephone Conference Call).
period on June 30, 2015. Name of Committee: Center for Scientific Contact Person: Elaine Sierra-Rivera, Ph.D.,
It is determined that the SCDAC is in Review Special Emphasis Panel; Member Scientific Review Officer, Genes, Genomes,
Conflict: Neurological, Aging and and Genetics IRG, Center for Scientific
the public interest in connection with Musculoskeletal Epidemiology. Review, National Institutes of Health, 6701
the performance of duties imposed on Date: July 22, 2015. Rockledge Drive, Room 2200, MSC 7890,
the National Institutes of Health by law, Time: 1:00 p.m. to 5:00 p.m. Bethesda, MD 20892, 301 435–2514,
and that these duties can best be Agenda: To review and evaluate grant riverase@csr.nih.gov.
performed through the advice and applications. Name of Committee: Center for Scientific
counsel of this group. Place: National Institutes of Health, 6701 Review Special Emphasis Panel; PAR–13–
Rockledge Drive, Bethesda, MD 20892, 385: Epigenetics in Gametogenesis and
Inquires may be directed to Jennifer (Virtual Meeting). Transgenerational Inheritance.
Spaeth, Director, Office of Federal, Contact Person: George Vogler, Ph.D., Date: July 31, 2015.
Advisory Committee Policy, Office of Scientific Review Officer, Center for Time: 12:00 p.m. to 3:00 p.m.
the Director, National Institutes of Scientific Review, National Institutes of Agenda: To review and evaluate grant
Health, 6701 Rockledge Drive, Room 3140, applications.
Health, 6701 Democracy Boulevard,
MSC 7770, Bethesda, MD 20892, (301) 237– Place: National Institutes of Health, 6701
Suite 1000, Bethesda, Maryland 20892 2693, voglergp@csr.nih.gov. Rockledge Drive, Bethesda, MD 20892,
(Mail Code 4875), Telephone (301) 496– Name of Committee: Center for Scientific (Telephone Conference Call).
2123, or spaethj@od.nih.gov. Review Special Emphasis Panel; Member Contact Person: Gary Hunnicutt, Ph.D.,
Scientific Review Officer, Center for
Lhorne on DSK7TPTVN1PROD with NOTICES

Dated: June 30, 2015. Conflict: AIDS and AIDS Related Research.
Date: July 29, 2015. Scientific Review, National Institutes of
Michelle Trout, Health, 6701 Rockledge Drive, Room 6164,
Time: 10:00 a.m. to 5:00 p.m.
Program Analyst, Office of Federal Advisory Agenda: To review and evaluate grant MSC 7892, Bethesda, MD 20892, 301–435–
Committee Policy. applications. 0229, gary.hunnicutt@nih.gov.
[FR Doc. 2015–16524 Filed 7–2–15; 8:45 am] Place: National Institutes of Health, 6701 Name of Committee: Center for Scientific
BILLING CODE 4140–01–P
Rockledge Drive, Bethesda, MD 20892, Review Special Emphasis Panel; Member
(Telephone Conference Call). Conflict: AIDS and AIDS Related Research.

VerDate Sep<11>2014 14:37 Jul 02, 2015 Jkt 235001 PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 E:\FR\FM\06JYN1.SGM 06JYN1

Document Created: 2015-12-15 13:17:45
Document Modified: 2015-12-15 13:17:45

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 23, 2015.
FR Citation		80 FR 38450

80 FR 38450 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 128 (July 6, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health